Cargando…

Antifibrotic Effects of Hepatocyte Growth Factor on Endothelial-to-Mesenchymal Transition via Transforming Growth Factor-Beta1 (TGF-β1)/Smad and Akt/mTOR/P70S6K Signaling Pathways

BACKGROUND: The related mechanisms involved in allograft interstitial fibrosis and chronic allograft dysfunction (CAD), following renal transplant, remain largely unknown. Here, we explored the role of hepatocyte growth factor (HGF) treatment on the endothelial-to-mesenchymal transition (EndMT) as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zijie, Fei, Shuang, Suo, Chuanjian, Han, Zhijian, Tao, Jun, Xu, Zhen, Zhao, Chunchun, Tan, Ruoyun, Gu, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248046/ https://www.ncbi.nlm.nih.gov/pubmed/29292365 http://dx.doi.org/10.12659/AOT.906700

Ejemplares similares

Bortezomib attenuates renal interstitial fibrosis in kidney transplantation via regulating the EMT induced by TNF‐α‐Smurf1‐Akt‐mTOR‐P70S6K pathway
por: Zhou, Jiajun, et al.
Publicado: (2019)

mTOR inhibition by rapamycin increases ceramide synthesis by promoting transforming growth factor‐β1/Smad signaling in the skin
por: Yamane, Takumi, et al.
Publicado: (2016)

Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis
por: Murray, Lynne A., et al.
Publicado: (2017)

Evaluation of the NMP22 BladderChek test for detecting bladder cancer: a systematic review and meta-analysis
por: Wang, Zijie, et al.
Publicado: (2017)

Role of endothelial‐to‐mesenchymal transition induced by TGF‐β1 in transplant kidney interstitial fibrosis
por: Wang, Zijie, et al.
Publicado: (2017)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Mitochondrial AKAP1 supports mTOR pathway and tumor growth
por: Rinaldi, Laura, et al.
Publicado: (2017)

Single-nucleotide polymorphisms of matrix metalloproteinase genes are associated with graft fibrosis after kidney transplantation
por: Zhang, Hengcheng, et al.
Publicado: (2023)

Radiofrequency ablation in combination with an mTOR inhibitor restrains pancreatic cancer growth induced by intrinsic HSP70
por: Gao, Shanshan, et al.
Publicado: (2020)

Heparin-Binding EGF-Like Growth Factor Induces Heart Interstitial Fibrosis via an Akt/mTor/p70s6k Pathway
por: Lian, Hong, et al.
Publicado: (2012)

Hepatocyte growth factor and the hepatocyte growth factor receptor signalling complex as targets in cancer therapies
por: Jiang, W.G.
Publicado: (2007)

Localization of αυβ6 Integrin-TGF-β1/Smad3, mTOR and PPARγ in Experimental Colorectal Fibrosis
por: Latella, G., et al.
Publicado: (2013)

mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma
por: Scheller, T, et al.
Publicado: (2015)

Direct regulation of fibroblast growth factor 23 by energy intake through mTOR
por: Vidal, Angela, et al.
Publicado: (2020)

Protocol for the assessment of mTOR activity in mouse primary hepatocytes
por: Plata-Gómez, Ana Belén, et al.
Publicado: (2021)

Knockdown of anion exchanger 2 suppressed the growth of ovarian cancer cells via mTOR/p70S6K1 signaling
por: Zhang, Li-Jun, et al.
Publicado: (2017)

α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway
por: Saraswati, Sarita, et al.
Publicado: (2013)

Hepatocyte growth factor, hepatocyte growth factor activator and arginine in a rat fulminant colitis model
por: Zwintscher, Nathan P., et al.
Publicado: (2016)

From the Gut to the Lung: Evidence of Antifibrotic Activity of Endocrine Fibroblast Growth Factor 19
por: Guzy, Robert D., et al.
Publicado: (2022)

Activation of the Connective Tissue Growth Factor (CTGF)-Transforming Growth Factor β 1 (TGF-β 1) Axis in Hepatitis C Virus-Expressing Hepatocytes
por: Nagaraja, Tirumuru, et al.
Publicado: (2012)

AT-MSCs Antifibrotic Activity is Improved by Eugenol through Modulation of TGF-β/Smad Signaling Pathway in Rats
por: Fathy, Moustafa, et al.
Publicado: (2020)

Nutrient withdrawal rescues growth factor-deprived cells from mTOR-dependent damage
por: Panieri, Emiliano, et al.
Publicado: (2010)

Hepatocyte Growth Factor and Cardiac Amyloidosis
por: Ruberg, Frederick L., et al.
Publicado: (2020)

Platelet-derived growth factor-induced Akt phosphorylation requires mTOR/Rictor and phospholipase C-γ1, whereas S6 phosphorylation depends on mTOR/Raptor and phospholipase D
por: Razmara, Masoud, et al.
Publicado: (2013)

Cyclopamine and Rapamycin Synergistically Inhibit mTOR Signalling in Mouse Hepatocytes, Revealing an Interaction of Hedgehog and mTor Signalling in the Liver
por: Spormann, Luise, et al.
Publicado: (2020)

The effect of transforming growth factor-β1 on nasopharyngeal carcinoma cells: insensitive to cell growth but functional to TGF-β/Smad pathway
por: Xiao, Jian, et al.
Publicado: (2010)

Correction: Activation of the Connective Tissue Growth Factor (CTGF)-Transforming Growth Factor β 1 (TGF-β 1) Axis in Hepatitis C Virus-Expressing Hepatocytes
por: Nagaraja, Tirumuru, et al.
Publicado: (2023)

Sin1-mediated mTOR signaling in cell growth, metabolism and immune response
por: Ruan, Chun, et al.
Publicado: (2019)

Retraction Note: α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway
por: Saraswati, Sarita, et al.
Publicado: (2022)

Enhanced asthma-related fibroblast to myofibroblast transition is the result of profibrotic TGF-β/Smad2/3 pathway intensification and antifibrotic TGF-β/Smad1/5/(8)9 pathway impairment
por: Wnuk, Dawid, et al.
Publicado: (2020)

Reinke's Edema: investigations on the role of MIB-1 and hepatocyte growth factor
por: Artico, M., et al.
Publicado: (2010)

Hepatocyte growth factor regulates the TGF-β1-induced proliferation, differentiation and secretory function of cardiac fibroblasts
por: YI, XIN, et al.
Publicado: (2014)

PD-L1 Status in Gastric Cancers, Association with the Transcriptional, Growth Factors, AKT/mTOR Components Change, and Autophagy Initiation
por: Spirina, Liudmila, et al.
Publicado: (2021)

Evaluation of the antifibrotic potency by knocking down SPARC, CCR2 and SMAD3
por: Ding, Weifeng, et al.
Publicado: (2018)

Partial-Hepatectomized (70%) Model Shows a Correlation between Hepatocyte Growth Factor Levels and Beta-Cell Mass
por: Araújo, Tiago G., et al.
Publicado: (2015)

Associations between HVEM/LIGHT/BTLA/CD160 polymorphisms and the occurrence of antibody-mediate rejection in renal transplant recipients
por: Wang, Zijie, et al.
Publicado: (2017)

The mTOR/AP-1/VEGF signaling pathway regulates vascular endothelial cell growth
por: Wang, Shuo, et al.
Publicado: (2016)

mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development
por: Molina, Laura, et al.
Publicado: (2019)

Hepatocyte nuclear factor 1 alpha influences pancreatic cancer growth and metastasis
por: Subramani, Ramadevi, et al.
Publicado: (2020)

Involvement of placental growth factor upregulated via TGF-β1-ALK1-Smad1/5 signaling in prohaptoglobin-induced angiogenesis
por: Oh, Mi-Kyung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ghjeqrg16tatvt1rve80e2it92